Andrew Huberman Ashwagandha: What He Actually Recommends

Search "Andrew Huberman ashwagandha" and you'll find dozens of articles that simply parrot his on-air recommendations without checking whether the studies actually say what he claims they say. This article does something different: we took every specific ashwagandha claim Huberman has made across his podcast episodes and social media, then cross-referenced each one against the primary clinical literature to show where the evidence firmly supports him, where it's thinner than he implies, and what he leaves out entirely.

The result isn't a takedown or a fan page — it's a practical, evidence-grounded guide to Andrew Huberman's ashwagandha protocol that helps you decide whether this adaptogen belongs in your own routine in 2026.

What Exactly Does Andrew Huberman Say About Ashwagandha?

Huberman's ashwagandha recommendations, drawn primarily from episodes of the Huberman Lab podcast and his newsletter, boil down to five core claims:

1. Dosage: 300–600 mg per day of a standardised extract (KSM-66 or Sensoril).
2. Timing: Take it in the evening, because it may lower cortisol and support sleep.*
3. Cycling: Use it for 2–4 weeks, then take a break — don't run it continuously.
4. Primary benefit: Significant cortisol reduction, leading to lower subjective stress and anxiety.*
5. Caution: Ashwagandha may affect thyroid hormones, so people with thyroid conditions should be especially careful.

Let's test each claim against the published data.

Claim 1: 300–600 mg of KSM-66 or Sensoril — What the Evidence Shows

Verdict: Strongly supported. The 300–600 mg range is the dose used in the majority of positive clinical trials. A 2012 randomised controlled trial published in the Indian Journal of Psychological Medicine gave 64 adults with chronic stress 300 mg of KSM-66 twice daily (600 mg total) for 60 days. The ashwagandha group saw a 27.9% reduction in serum cortisol compared to placebo — one of the largest effect sizes reported for any over-the-counter adaptogen (Chandrasekhar et al., 2012).

A separate 8-week trial using 240 mg of Sensoril daily also found significant reductions in perceived stress and morning cortisol (Lopresti et al., 2019). Huberman's dosage recommendation sits squarely within the clinically validated range.

What Huberman doesn't emphasise: The difference between KSM-66 and Sensoril matters more than most people realise. KSM-66 is a root-only extract standardised to roughly 5% withanolides; Sensoril is a root-and-leaf extract with 10%+ withanolides. The higher withanolide concentration in Sensoril means effective doses can be lower. If your supplement doesn't specify which extract it uses, you're guessing at potency.

Claim 2: Evening Timing for Cortisol and Sleep — Where He's Right and Where It's Nuanced

Verdict: Partially supported. There is reasonable evidence that ashwagandha may help support sleep quality.* A 2019 double-blind trial in Cureus found that 300 mg of KSM-66 taken twice daily improved sleep onset latency, total sleep time, and sleep quality scores over 10 weeks (Langade et al., 2019).

However, Huberman's specific recommendation to take it only in the evening oversimplifies the data. Most trials dosed ashwagandha twice daily (morning and evening), not exclusively at night. The cortisol-lowering effect operates over days and weeks, not within a single-dose window the way melatonin does.

Practical takeaway: Evening dosing is sensible if ashwagandha makes you feel drowsy, but there's no strong evidence that it must be taken at night to work. "Twice daily works just as well — possibly better, since it keeps blood levels more consistent throughout the day."

Claim 3: Cycling 2–4 Weeks On, Then Off — The Weakest Part of His Protocol

Verdict: Theoretically reasonable, but not clinically validated. This is the Andrew Huberman ashwagandha recommendation with the least published support. No randomised trial has directly compared continuous versus cycled ashwagandha use for stress or cognitive outcomes.

Huberman's rationale centres on ashwagandha's potential to raise thyroid hormones (T3 and T4). A 2018 case study in the Journal of the Endocrine Society reported thyrotoxicosis in a young woman taking ashwagandha, and a 2014 case report described similar findings. These are important signals — but case reports are the lowest tier of clinical evidence.

Meanwhile, the largest positive trials ran ashwagandha continuously for 8–12 weeks without reported thyroid complications. The cycling protocol Huberman recommends is a precautionary measure, not one backed by direct comparative data.

Our position: Cycling is a reasonable risk-management strategy, especially if you haven't had your thyroid levels checked recently. But if a 2-week cycle works for you, you're also cutting your supplementation short of the 8-week mark where most studies show peak benefits. That's a genuine trade-off Huberman rarely acknowledges.

Claim 4: Significant Cortisol Reduction — Strong Evidence, with Caveats

Verdict: Well supported in stressed populations; less clear in healthy, non-stressed individuals. The 27.9% cortisol reduction figure from the Chandrasekhar (2012) trial is real — but that trial specifically recruited adults reporting chronic stress. If your baseline cortisol is already in a healthy range, ashwagandha's effect may be more modest.*

A 2021 systematic review and meta-analysis in the Journal of Ethnopharmacology analysed 12 RCTs and confirmed that ashwagandha significantly reduced cortisol and anxiety scores across studies — but effect sizes varied substantially depending on baseline stress levels and extract type.

"Ashwagandha is one of the few adaptogens where the cortisol claim actually holds up under scrutiny — but it's a stress-management tool, not a cognitive enhancer in the traditional sense."

Claim 5: Thyroid Concerns — Where Huberman Is Appropriately Cautious

Verdict: Legitimate concern, though the risk magnitude is unclear. Ashwagandha does appear to influence thyroid hormone levels. An 8-week RCT published in the Journal of Alternative and Complementary Medicine (2018) found that 600 mg of KSM-66 daily significantly increased serum T4 levels in subclinical hypothyroid patients. For people with low thyroid function, this might actually be beneficial. For those with normal or elevated thyroid function, it warrants monitoring.

Huberman is right to flag this. If you have a thyroid condition, are taking thyroid medication, or have a family history of thyroid disease, consult your doctor before taking ashwagandha.

What Huberman Leaves Out: Ashwagandha in a Broader Nootropic Stack

Huberman typically discusses ashwagandha in isolation — as a stand-alone stress and sleep tool. What he rarely addresses is how it fits alongside other nootropics that target different cognitive pathways.

Because ashwagandha primarily modulates cortisol and GABA-related pathways, it complements rather than duplicates focus-oriented compounds like:

• L-theanine — promotes alpha brain wave activity for calm alertness within 30–45 minutes.*
• Citicoline — supports acetylcholine production for sustained attention, with effects building over 4 weeks.*
• Phosphatidylserine — may help support both working memory and cortisol regulation in 2–4 weeks.*

If stress is undermining your focus, ashwagandha addresses the root cause (elevated cortisol) while compounds like citicoline and L-theanine directly support the cognitive processes you're trying to protect. That layered approach is more effective than any single ingredient alone.

Noobru Advantage combines several of these complementary compounds — including citicoline, phosphatidylserine, and L-theanine — in a single drinkable sachet. It doesn't contain ashwagandha, which means you can pair it with your own ashwagandha cycling protocol without overlap or redundancy.

A Realistic Ashwagandha Protocol for 2026 (Informed by Huberman, Adjusted by Evidence)

Based on our cross-referencing of Huberman's claims with the clinical literature, here's the protocol we'd actually recommend:

Key Takeaways

• Andrew Huberman's ashwagandha dosage (300–600 mg KSM-66 or Sensoril) is well supported by clinical trials showing up to 27.9% cortisol reduction in stressed adults.*
• Evening-only timing is a personal preference, not a clinical requirement — twice-daily dosing matches most study protocols.
• The 2–4 week cycling protocol is the least evidence-backed part of his advice; most benefits don't peak until week 8.
• Thyroid concerns are legitimate but based on case reports, not RCTs — monitoring is wise, panic is not.
• Ashwagandha pairs well with focus-oriented nootropics like citicoline and L-theanine that target different pathways.*
• Noobru Advantage combines several complementary compounds and can be used alongside your own ashwagandha protocol without ingredient overlap.

Frequently Asked Questions

What ashwagandha dosage does Andrew Huberman recommend?

Huberman has recommended 300–600 mg per day of a standardised ashwagandha extract, typically KSM-66 or Sensoril, taken in the evening due to its cortisol-lowering and sleep-supportive effects. This dosage range aligns with the majority of positive clinical trials.

Does Andrew Huberman cycle ashwagandha?

Yes. Huberman has stated he uses ashwagandha in cycles of roughly 2–4 weeks on, then takes a break, rather than supplementing continuously. He cites concerns about potential thyroid hormone changes with long-term uninterrupted use, though no RCT has directly tested this cycling approach.

Is ashwagandha safe to take every day?

Clinical trials lasting up to 8–12 weeks show a strong safety profile for standardised ashwagandha extracts at 300–600 mg daily. However, long-term data beyond 12 weeks is limited, which is why some experts recommend cycling. Always consult your healthcare provider before starting any supplement.

Can you take ashwagandha with other nootropics?

Yes — ashwagandha is commonly stacked with nootropics that target different mechanisms, such as L-theanine for calm focus or citicoline for attention. Because ashwagandha primarily modulates cortisol and GABA pathways, it complements rather than duplicates most focus-oriented compounds.*

What is the difference between KSM-66 and Sensoril ashwagandha?

KSM-66 is a full-spectrum root extract standardised to roughly 5% withanolides, while Sensoril is a root-and-leaf extract standardised to 10%+ withanolides. KSM-66 has more clinical trials supporting cognitive and athletic performance outcomes; Sensoril tends to show stronger acute cortisol reduction. Both are legitimate choices — what matters is knowing which one your supplement contains.

References

1. Chandrasekhar, K. et al. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of Ashwagandha root. Indian Journal of Psychological Medicine, 34(3), 255–262. PubMed
2. Lopresti, A.L. et al. (2019). An investigation into the stress-relieving and pharmacological actions of an ashwagandha extract. Medicine, 98(37), e17186. PubMed
3. Langade, D. et al. (2019). Efficacy and safety of Ashwagandha root extract on sleep quality in insomnia and anxiety. Cureus, 11(9), e5797. PubMed
4. Sharma, A.K. et al. (2018). Efficacy and safety of Ashwagandha root extract in subclinical hypothyroid patients. Journal of Alternative and Complementary Medicine, 24(3), 243–248. PubMed
5. Salve, J. et al. (2019). Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults. Cureus, 11(12), e6466. PubMed

Want a focus stack that complements ashwagandha?
Try Noobru Advantage — citicoline, L-theanine, and phosphatidylserine in one daily sachet. No ashwagandha overlap, by design.

*These statements have not been evaluated by the Food and Drug Administration or MHRA. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any supplement regimen.

---

Related reading

• Ashwagandha for Anxiety: What the Science Actually Says
• Ashwagandha Supplement: The Complete Guide to Benefits, Dosage & What to Look For
• Best Supplements for Focus and Concentration (2026)